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Secondary macular hole(MH) formation after vitrectomy is rare and its risk factors and pathogenesis 
are not clearly understood. this retrospective study was conducted to identify the risk factors of 
this complication and assess outcomes at 2 tertiary centres. The primary outcomes were the clinical 
characteristics associated with development of secondary MH, which included the primary diagnosis 
for initial vitrectomy, features on optical coherence tomography, and adjuvant surgical techniques 
used during the initial surgery. Secondary outcomes included the change in best-corrected visual 
acuity(BcVA), clinical factors associated with the need for re-operations for MH closure and prognostic 
factors for the visual outcomes. Thirty-eight eyes out of 6,354 cases (incidence 0.60%) developed 
secondary MH after undergoing vitrectomy for various vitreoretinal disorders over an 11-year period, 
most frequently after initial surgery for retinal detachment(RD) (9 eyes) and secondary epiretinal 
membrane (6 eyes). The mean age was 57.1 years (range: 17.8–76.7), and the mean follow-up was 51.1 
months (range: 6.8 to 137.6). Prior to secondary MH formation, development of ERM was the most 
common OCT feature (19 eyes, 50%), and no cases of cystoid macular oedema (CME) were observed. 
A greater proportion of eyes with secondary MH had long axial lengths (32% ≥26 mm vs 5% of eyes 
≤22 mm). MH closure surgery was performed in 36 eyes and closure was achieved in 34 (success rate 
94%, final BCVA 20/86), with ≥3-line visual gain in 18 cases. BCVA at MH onset (OR = 0.056, P = 0.036), 
BCVA at post-MH surgery month 3 (OR = 52.671, P = 0.011), and axial length ≥28 mm (OR = 28.487, 
p = 0.030) were associated with ≥3-line visual loss; a history of macula-off RD (OR = 27.158, P = 0.025) 
was associated with the need for multiple surgeries for MH closure. in conclusion, secondary MH occurs 
rarely but most commonly after vitrectomy for RD. patients with axial length ≥28 mm and poor BCVA 
at 3 months post-operation may have limited visual prognosis; those with a history of macula-off RD 
may require multiple surgeries for hole closure.
Secondary full-thickness macular hole (MH) formation after vitrectomy is a rare surgical complication, with an 
incidence reportedly between 0.24% and 1.9%1–3. Unfortunately, the factors contributing to the development of 
a postoperative secondary MH in the absence of intact vitreous are not well-understood, and pathogenic mecha-
nisms other than those for idiopathic MH may be involved. An idiopathic MH is generally believed to be formed 
as a result of interactions between various forces on the fovea, mainly from anteroposterior and tangential trac-
tion by the vitreous4,5. Therapeutic surgical intervention thus attempts to relieve these tractional components 
through vitrectomy, with or without internal limiting membrane (ILM) peeling, with favourable outcomes6,7. 
However, for post-vitrectomized eyes, the thorough detachment of the vitreous from the posterior pole and its 
removal eliminates these crucial pathogenic elements.
Current literature describes cases of secondary MH after surgical repair of retinal detachments (RD)8, epiret-
inal membranes (ERM)2, vitreomacular traction syndrome (VMTS)9, and myopic foveoschisis10. These studies 
also document a wide combination of adjuvant techniques used during the initial vitrectomy, such as ILM peel-
ing, scleral buckling, and pneumatic tamponade11. Many of the aforementioned studies also report that the vit-
reous was already detached prior to the primary vitrectomy12. Suggestions for possible aetiologies for secondary 
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MH formation include foveal cystic degeneration, iatrogenic trauma, secondary ERM tangential contraction, and 
vitreoschisis8. However, the small sample sizes in these previous studies, wide diversity of clinical characteristics, 
and varied outcomes pose difficulties in identifying common risk factors for the development of secondary MH.
In this present study, we analysed a relatively large number of cases to investigate the clinical spectrum of 
a secondary MH that develops after vitrectomy and assess the treatment outcomes. Additionally, we sought to 
identify the risk factors that contribute to the development of secondary MH and the requirement of multiple 
surgeries for MH closure, and determine the predictive factors for long-term visual prognosis.
Results
A total of 38 eyes from 37 patients were included in this study, identified from 6,354 cases of patients who under-
went vitrectomy, with an incidence of 0.60%. The baseline characteristics are summarized in Table 1. Secondary 
MH was diagnosed after a median duration of 2.3 months after the initial primary vitrectomy. The mean age at 
MH onset was 57.1 years, although it ranged from 17.8 to 76.7 years, and the mean onset BCVA was 1.02 (Snellen 
20/210). There was no apparent predilection for sex; however, a greater proportion of the diseased eyes had long 
axial lengths (5% of eyes ≤ 22 mm vs. 32% ≥26 mm). The mean total follow-up duration was 51.1 months (range: 
6.8 to 137.6 months).
The primary diagnoses for the initial vitrectomy, co-existing ocular pathologies detected on multimodal imag-
ing, and adjuvant techniques used can be found in Table 2. The most common primary diagnoses for the initial 
vitrectomy, when defined as the principal reason for initial surgical treatment, were rhegmatogenous RD (9 eyes, 
24%; 5 macula-off cases) and secondary ERM (6 eyes, 16%). When combining cases of primary rhegmatogenous 
RD (9 eyes) with those undergoing silicone oil removal after successful repair of RD with silicone oil tamponade 
(oil-filled status, 5 eyes) and those having had a history of RD (n = 3), we found that altogether 17 cases (45%) 
had some association with RD.
Review of the multimodal imaging data of all involved eyes, before the initial vitrectomy, revealed a wide 
variety of co-existing vitreomacular pathologies in addition to the primary diagnosis, such as ERM detected in 
22 eyes (58%), vitreous haemorrhage in 11 eyes (29%), retinoschisis in 5 eyes (13%), and lamellar holes in 4 eyes 
(11%) (Table 2). An intact subfoveal inner segment/outer segment line was observed on the OCT of 16 eyes (73%) 
pre-operatively and only 8 eyes (35%) post-initial vitrectomy. The mean central macular thickness was measured 
at 215.8 ± 173.1 μm preoperatively and 113.4 ± 61.8 μm post-operatively.
Next, we have summarized the clinical features detected after secondary MH formation (post-initial primary 
vitrectomy), and the intraoperative factors and surgical outcomes for MH closure in Table 3. We detected ERM in 
19 eyes (50%): recurred ERM in 14 eyes and newly developed ERM in 5. We observed that all 4 cases of idiopathic 
ERM exhibited recurrence following the initial primary vitrectomy. No cases of cystoid macular oedema (CME) 
were detected prior to secondary MH formation.
Surgery for MH closure was performed in 36 eyes; the intraoperative factors and treatment outcomes are 
summarized in Table 3. In the 2 cases that did not receive surgery, the patients refused treatment due to other 
debilitating illnesses, and were, therefore, managed conservatively. Successful closure, as detected on OCT, was 
achieved in 34 eyes (94%) after a mean 1.3 operations. In majority of the eyes, ILM peeling was attempted (32 
eyes, 89%); however, no ILM staining was observed in 3 eyes (8%). Furthermore, ILM transplantation (3 eyes, 
8%) and heavy silicone oil injection (1 eye, 3%) was performed in eyes requiring multiple operation for closure. 
Representative images from several cases can be seen in patients with idiopathic ERM (Fig. 1), macula-off RD 
(Fig. 2), macular telangiectasia (Fig. 3), and submacular haemorrhage (Fig. 4).
Sex, no. (%)
  Male 18 (49)
  Female 19 (51)
Hypertension, no. (%) 9 (24)
Diabetes mellitus, no. (%) 9 (24)
Age at primary vitrectomy, years, mean ± SD (range) 55.7 ± 14.1 (17.6–75.4)
  Age at onset of MH 57.1 ± 14.6 (17.8–76.7)
Median time to MH diagnosis after vitrectomy, months (range) 2.3 (0.4–90.9)
Prior vitrectomy operations, no. (range) 1.2 ± 0.5 (1–3)
BCVA, logMAR, mean ± SD (Snellen)
  Prior to primary vitrectomy 1.19 ± 0.9 (20/313)
  Onset of MH 1.02 ± 0.6 (20/210)
Axial length, mm, mean ± SD (range) 25.1 ± 2.7 (21.5–32.3)
  Short eye (≤22 mm), no. (%) 2 (5)
  Average eye (22–26 mm), no. (%) 24 (63)
  Long eye (≥26 mm), no. (%) 12 (32)
  Very long eye (≥28 mm), no. (%) 6 (16)
Pseudophakic status, no. (%) 28 (74)
Table 1. Baseline patient characteristics (37 patients, n = 38 eyes). BCVA = best-correct visual acuity; 
logMAR = logarithm of minimum angle of resolution; MH = macular hole; SD = standard deviation.
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Visual outcomes and clinical factors. The mean BCVA at the most recent follow-up was 0.77 (20/119), 
with the majority (24 eyes, 63.2%) having improved at least 1 line (Table 3). A visual loss of greater than 3 lines 
was noted in 7 eyes (18%). Multivariable analyses found that the preoperative BCVA (odds ratio [OR] = 0.056, 
P = 0.036), BCVA at postoperative month 3 (OR = 52.671, P = 0.030), and axial length ≥28 mm (OR = 28.487, 
P = 0.030) significantly influenced a 3-line visual loss by the final follow-up (Table 4). The size of MH was 
not found to be a significant factor for visual outcome in our regression analysis (OR = 1.000 (0.997–1.002), 
P = 0.726).
With regard to clinical factors predictive of requirement of multiple surgeries for MH closure, multivariable 
regression analysis revealed that a history of macula-off RD (OR = 27.158, P = 0.025) significantly affected the 
outcome of Table 4. Other factors, such as MH size on preoperative OCT (OR = 1.004, P = 0.202), presence of 
perioperative ERM (OR = 0.231, P = 0.230), and BCVA at the most recent follow-up (OR = 1.847, P = 0.586), 
were only significant in the univariate analyses.
Discussion
Secondary MH after vitrectomy occurs rarely, with an incidence of 0.60% in our 11-year retrospective review. 
While both tangential and anteroposterior traction are thought to be central to the pathogenesis of idiopathic 
MH, subsequent studies using OCT have demonstrated that a predominantly anteroposterior orientation of trac-
tional forces play a more crucial role13. Postoperative MH in the setting of absent vitreous, and therefore, no 
anteroposterior traction, however, raise questions regarding the responsible pathophysiology and underlying 
Primary diagnosis, no. (%) 38 (100)
  Rhegmatogenous RD (5 macula-off) 9 (24)
  Secondary epiretinal membrane 6 (16)
  Vitreous haemorrhage (4 PDR, 1 PCV) 5 (13)
  Oil-filled status after RD surgery (4 macula-off) 5 (13)
  Idiopathic epiretinal membrane 4 (11)
  Lamellar hole 3 (8)
  Submacular haemorrhage (2 PCV, 1 RAM) 3 (8)
  Vitreomacular traction syndrome 2 (5)
  Optic disc pit-associated maculopathy 1 (3)
Co-existing pathology and clinical features prior to initial vitrectomy, no. (%)
  Epiretinal membrane detected on OCT 22 (58)
  Vitreous attachment at fovea on OCT 22 (58)
  Vitreous haemorrhage 11 (29)
      PDR 4 (11)
      Breakthrough from SMH 3 (8)
      PCV 2 (5)
      Branch retinal vein occlusion 1 (3)
      RAM 1 (3)
  Retinoschisis 5 (13)
  Lamellar macular hole 4 (11)
  Past surgical history of macula-off RD 3 (8)
  Prior scleral encircling or buckling for RD 3 (8)
  Proliferative vitreoretinopathy 3 (8)
  Posterior uveitis 2 (5)
  Prior oil removal history after RD 1 (3)
  Serous neurosensory RD 1 (3)
  RAM 1 (3)
Adjuvant techniques for primary vitrectomy, no. (%)
  ILM peeling 20 (44)
  Pneumatic tamponade (SF6 or C3F8 gas) 16 (42)
  Silicone oil injection 12 (32)
  Scleral buckle/encircling 5 (13)
  Intravitreal anti-VEGF injection performed 12 (32)
      No. of injections, mean ± SD (range) 2.6 ± 2.0 (1–7)
  Intravitreal Ozurdex® injection performed 3 (8)
      No. of injections, mean ± SD (range) 1.7 ± 1.2 (1–3)
Table 2. Diagnoses, associated ocular pathologies, treatment factors, and imaging characteristics with regard 
to the primary initial vitrectomy. ILM = internal limiting membrane; OCT = optical coherence tomography; 
PDR = proliferative diabetic retinopathy; RAM = retinal arterial macroaneurysm; RD = retinal detachment; 
SD = standard deviation; SMH = submacular haemorrhage; VEGF = vascular endothelial growth factor.
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mechanisms3,11. In the present study, we examined our own experiences with this surgical complication, describ-
ing both the clinical spectrum and treatment outcomes, and have identified possible factors predictive of 
long-term prognosis.
There are currently two main theoretical mechanisms proposed for the aetiology of a secondary MH forma-
tion: the tangential forces from the formation of an ERM and the development of CME3. However, in our series, 
we did not detect any cases of CME after the primary vitrectomy and prior to the diagnosis of secondary MH. 
Instead, we noted a greater prevalence of ERM, as detected on the OCT images of 27 distinct eyes (71%) over-
all, both before and after the initial primary vitrectomy. These findings are similar to those of a recent study by 
Khurana et al.14, in which no eyes from 14 cases were found to have postoperative CME, but all eyes (100%) had 
ERM (Table 5). It is important to note that in our series, OCT imaging was not available during the immediate 
post-operative period and prior to secondary MH diagnosis for all the cases, either due to the difficulty in captur-
ing OCT images, such as after pneumatic tamponade, or irregular follow-up visits from the patients. Additionally, 
fluorescein angiography was not regularly performed after vitrectomy. Therefore, it is difficult to conclusively state 
that CME was not a factor for secondary MH development. However, it is revealing that we additionally observed 
secondary MH formation even in eyes that had received intraoperative Ozurdex®, which is a sustained-release 
intravitreal dexamethasone implant that, in theory, should drastically reduce ocular inflammation and CME.
Previous clinical observations have revealed that the presence of ERM may be involved in the late reopening 
of successfully treated MH15,16, suggesting that tractional forces from the ERM could be responsible. However, the 
risk of ERM formation can be reduced with ILM peeling manoeuvres to remove all residual cortical vitreous17. In 
our series, we noted that ILM peeling had been performed in 20 eyes during the initial primary vitrectomy and 
ERM recurrence was noted in 9 cases, which may have been because of incomplete ILM removal or an insuffi-
ciently broad area of peeling. However, there were several eyes in our series that did not develop postoperative 
ERM, and simply detecting the presence of a postoperative ERM may not prove causation, instead suggesting 
heterogeneity in the aetiology of this postoperative complication.
Another possible mechanism responsible for secondary MH may involve the iatrogenic traction created dur-
ing the induction of posterior vitreous detachment, ERM removal, or ILM peeling manoeuvres. A recent study by 
Sawaguchi et al.9 described a fascinating case of an MH developing intraoperatively during vitrectomy for VMTS, 
imaged on intraoperative OCT. As a result, the authors performed ILM peeling and pneumatic tamponade. 
MH size on pre-operative OCT, μm, mean ± SD (range) 543.9 ± 324.1
ERM on OCT (after the initial vitrectomy but prior to MH surgery), no. (%) 19 (50)
  Newly formed after the initial primary vitrectomy 5 (13)
  Recurrence after the initial primary vitrectomy & ERM removal 14 (37)
Surgery performed for MH closure, no. (%) 36 (95)
Adjuvant techniques during vitrectomy, no. (%)
  ILM peeling 29 (81)
       ILM transplantation 3 (8)
       No ILM staining observed 3 (8)
  Silicone oil injection 7 (19)
       Heavy silicone oil injection 1 (3)
Pneumatic tamponade
       C3F8 gas injection 26 (72)
       SF6 gas injection 6 (17)
  Autologous platelet concentrate injection 9 (25)
Closure of MH achieved, no. (%) 34 (94)
No. of operations to MH closure, mean ± SD (range) 1.3 ± 0.5 (1–3)
    Multiple operations required, no. (%) 10 (28)
Visual outcomes in BCVA, logMAR, mean ± SD (Snellen)
    At post-operation 3 months (38/38 eyes) 1.00 ± 0.6 (20/199)
    At post-operation 6 months (38/38 eyes) 0.86 ± 0.6 (20/144)
    At post-operation 12 months (30/38 eyes) 0.78 ± 0.6 (20/119)
    At post-operation 24 months (26/38 eyes) 0.63 ± 0.5 (20/86)
    Overall BCVA by the most recent follow-up 0.77 ± 0.7 (20/119)
        Mean BCVA change from MH onset to final visit, logMAR,, mean ± SD −0.25 ± 0.6
        Improved at least 3 lines, no. (%) 18 (47)
        Decreased in 3 lines, no. (%) 7 (18)
Follow-up duration, months, mean ± SD (range) 51.1 ± 39.1 (6.8–137.6)
Table 3. Clinical features after secondary macular hole formation: intraoperative factors and surgical 
outcomes. BCVA = best-corrected visual acuity; ERM = epiretinal membrane; ILM = internal limiting 
membrane; logMAR = logarithm of minimal angle of resolution; MH = macular hole; OCT = optical coherence 
tomography; SD = standard deviation.
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Additionally, previous studies consistently show a trend of MH formation after repair of RD involving the mac-
ula, but the underlying cause is yet to be fully understood11,18. This is similar to our own experience, where the 
majority of cases were associated with RD repair and multivariate analysis revealed that macula-off RD was the 
Figure 1. A 65-year-old woman underwent vitrectomy with internal limiting membrane (ILM) peeling for 
idiopathic epiretinal membrane (ERM) (A,B). Her best-corrected visual acuity (BCVA) was 20/133. Complete 
removal of ERM was noted on post-operative optical coherence tomography (OCT), although irregularity of 
the foveal depression remained (C,D). However, 1.7 months after the primary vitrectomy (BCVA 20/100), a 
secondary full-thickness macular hole (MH) was detected on OCT with thin ERM and no evidence of cystoid 
macular oedema (E,F). She subsequently underwent vitrectomy with ILM peeling and pneumatic tamponade 
with C3F8 gas. The MH remained closed 2.5 years’ post-operation, and her BCVA was 20/20 (G,H).
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most significant factor contributing to the need for multiple operations for MH closure. Altogether, these findings 
illustrate the complexity and possibly multifactorial nature of secondary MH formation. In the future, widespread 
use of intraoperative OCT may enable surgeons to consider the minute real-time changes in retinal architecture 
and further reduce complications.
Regarding the treatment outcomes, we found that the mean BCVA was improved at the final follow-up and 
more than 24 eyes (63%) showed greater than 1-line visual gain. This is similar to the results of recent studies by 
Lee et al.2 and Khurana et al.14 which also found good visual recovery after surgery, with a high closure rate. We 
noted that poor long-term visual prognosis was most significantly associated with very long eyes (axial length 
≥28 mm), BCVA at onset, and poor BCVA at postoperative month 3. Association of secondary MH with high 
myopia has also been found in previous studies11, and poorer visual recovery in longer eyes may be explained by 
the observation that in highly myopic eyes, the macula tends to degenerate and the fovea tends to thin19.
Figure 2. A man in his sixties underwent vitrectomy with pneumatic tamponade for macula-off retinal 
detachment in his right eye (A,B). His best-corrected visual acuity (BCVA) was 20/50. At postoperative week 5, 
the patient’s retina was well-attached (C); however, optical coherence tomography (OCT) revealed microscopic 
changes in foveal architecture and outer retinal layer discontinuity (D). Follow-up examination at postoperative 
week 8 (BCVA 20/67) revealed a secondary full-thickness macular hole (MH) with epiretinal membrane and 
without cystoid macular oedema (E). The patient underwent two additional vitrectomies with pneumatic 
tamponade and internal limiting membrane peeling for secondary MH closure. His most recent visit, at 3 years’ 
post-operation, revealed a BCVA of 20/29 with a closed MH, as observed on OCT (F,G).
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In our case series, we observed that multiple operations were required in 10 cases (28%), which is low com-
pared with the results of a study by Medina et al.11 (7 out of 15 eyes, 47%). However, this may be explained by the 
diversity of the primary diseases in our series, as the aforementioned study only included eyes with secondary 
Figure 3. A 61-year-old woman underwent vitrectomy with wide internal limiting membrane (ILM) peeling 
for symptomatic lamellar hole due to type 2 macular telangiectasia (A,B). Her best-corrected visual acuity 
(BCVA) was 20/40. At postoperative day 5, imaging revealed a full-thickness macular hole (MH) with no 
evidence of cystoid macular oedema (C,D), and the patient’s BCVA decreased to 20/100. Additional pneumatic 
retinopexy was performed twice subsequently but the size of the MH continued to increase (E,F). After two 
further vitrectomies with ILM peeling and injection of autologous platelet concentrate, MH closure was finally 
achieved. Three years’ post-operation, the patient had a BCVA of 20/67 with a closed MH, as observed on 
optical coherence tomography (G,H).
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Figure 4. A woman in her early sixties with known submacular haemorrhage secondary to polypoidal 
choroidal vasculopathy, diagnosed based on typical multimodal imaging findings (A–C), underwent vitrectomy 
for breakthrough vitreous haemorrhage, which occurred after 2 intravitreal injections of anti-vascular 
endothelial growth factor (D). Her best-corrected visual acuity (BCVA) prior to initial vitrectomy was counting 
fingers. At post-operative month 2, multimodal imaging revealed a large subretinal hyperreflective material 
remaining under the fovea, although no definite macular hole (MH) was yet to be found (E,F). However, 2 
months later, after continual intravitreal anti- vascular endothelial growth factor injections, imaging studies 
revealed the formation a large secondary macular hole with localized retinal detachment (G,H) and her onset 
BCVA was 20/667. She subsequently underwent multiple vitrectomies for MH closure: internal limiting 
membrane peeling and pneumatic tamponade was performed initially. Additional surgery with injection of 
autologous platelet concentrate and silicone oil was implemented. Finally, once MH closure was evidenced 
on optical coherence tomography (OCT), silicone oil removal operation was performed. Her most recent 
examination, at 2 years after initial vitrectomy, revealed a well-closed MH on OCT (I,J) and a BCVA of 20/200.
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MH after RD repair. In cases requiring multiple operations, we used a maximal approach with a combination of 
adjuvant surgical manoeuvres such as ILM transplantation and autologous platelet injection for physiologic mate-
rial to close the MH, longer and more substantial mechanical pressure with injection of silicone oil and heavy 
silicone oil, and relieving of traction by thorough ILM peeling. Utilizing such methods, we successfully achieved 
MH closure in 34 eyes (94%). Our findings suggest that, to improve the success rate of a single operation, greater 
caution may be required for eyes with a larger MH size, presence of perioperative ERM, and history of macula-off 
RD, although only the last clinical factor was significant in multivariate analysis.
Although, to our knowledge, the current series is the largest describing secondary MH formation, it has sev-
eral limitations due to its retrospective design with variable follow-up and without appropriate controls. The 
study population was limited to Asian patients in a tertiary university hospital setting. Finally, irregular patient 
follow-up and lack of immediate post-operative OCT may have led to delays in MH diagnosis. However, the 
strengths of this study include a large number of patients with a mean follow-up duration longer than 51 months, 
and treatment of all the patients at tertiary referral-based centres by experienced surgeons.
In summary, we found that secondary MH occurs rarely after vitrectomy, and the most commonly associated 
diagnosis was rhegmatogenous RD. Secondary ERM were noted in majority of the cases, suggesting that tangen-
tial forces may be the most important cause of this surgical complication. Although we observed that secondary 
MH can be successfully treated in most cases, patients with a history of macula-off RD may require multiple 
surgeries for hole closure, and those with very long eyes and poor BCVA at 3 months post-operation may have 
limited visual prognosis.
Methods
This retrospective study was conducted at two tertiary referral-based hospitals, Severance Hospital and Gangnam 
Severance Hospital, affiliated with Yonsei University College of Medicine. Consecutive patients who underwent 
vitrectomy from January 2006 to December 2016 were examined, and cases that developed a postoperative sec-
ondary MH were identified for inclusion. Institutional Review Board (Severance Hospital & Gangnam Severance 
Hospital, Yonsei University Health System) approval was obtained, and informed patient consent was acquired. 
The study adhered to the tenets of the Declaration of Helsinki.
We reviewed the complete electronic medical records and multimodal imaging data of the identified cases. 
Multimodal imaging data, when available, included data from fundus photography, ultra-wide field scanning 
laser ophthalmoscopy (Optomap®; Optos PLC, Dunfermline, UK), fluorescein and indocyanine-green angiogra-
phy using a confocal scanning system (HRA-2; Heidelberg Engineering Inc., Heidelberg, Germany), and optical 
coherence tomography (OCT) (Heidelberg Spectralis from Heidelberg Engineering Inc., Heidelberg, Germany; 
or Cirrus HD-OCT from Carl Zeiss Meditec, Inc., Dublin, CA, USA).
Basic demographic parameters, including age, sex, follow-up duration, and medical histories, were obtained. 
The primary diagnosis for vitrectomy prior to secondary MH formation was determined through examination 
of both electronic charts and imaging data. Patients who had undergone initial surgery for MH were excluded. 
Macular holes were defined as full-thickness defects of the neurosensory retina at the foveal centre as detected 
on OCT.
Additional macular pathologies (such as the presence of ERM, retinal/submacular haemorrhages, age-related 
macular degeneration, retino/foveoschisis, foveal cystic changes, etc.) and vitreoretinal pathologies (proliferative 
diabetic retinopathies, retinal artery/vein occlusions, VMTS, posterior vitreous detachment, vitreous haemor-
rhage, etc.) both before and after the primary vitrectomy, as well as the history of surgical interventions (scleral 
encircling/buckling, intravitreal injections, pneumatic retinopexy, laser photocoagulation, cataract surgery, etc.) 
were documented.
Factors influencing a 3-line visual gain by the most recent follow-up
OR (95% CI) P value
  BCVA, preoperative (prior to MH surgery) (logMAR) 9.814 (1.201–80.204) 0.033*
  BCVA, post-operation 3 months (logMAR) 0.093 (0.011–0.778) 0.028*
Factors influencing a 3-line visual loss by the most recent follow-up
OR (95% CI) P value
  BCVA, preoperative (prior to MH surgery) (logMAR) 0.056 (0.004–0.825) 0.036*
  BCVA, post-operation 3 months (logMAR) 52.671 (2.436–1138.719) 0.011*
  Axial length ≥28 mm 28.487 (1.380–587.960) 0.030*
Factors influencing the need for multiple surgeries for MH closure
OR (95% CI) P value
  MH size on pre-operative OCT 1.004 (0.998–1.009) 0.202
  BCVA, most recent follow-up (logMAR) 1.847 (0.203–16.785) 0.586
  History of macula-off RD 27.158 (1.526–483.204) 0.025*
  Presence of perioperative epiretinal membrane 0.231 (0.021–2.520) 0.230
Table 4. Multivariable analyses of surgical and visual outcomes. BCVA = best-corrected visual acuity; 
CI = confidence interval; logMAR = logarithm of minimal angle of resolution; MH = macular hole; OR = odds 
ratio; RD = retinal detachment; *P < 0.05.
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All vitrectomies were performed using either a 23- or 25-gauge system (Constellation® Vision System; Alcon 
Laboratories, Fort Worth, TX, USA) depending on the surgeon’s preference. Adjuvant techniques that were uti-
lized during either the primary vitrectomy or subsequent vitrectomies for MH closure were noted, such as ILM 
peeling and/or transplantation, laser photocoagulation, pneumatic tamponade, silicone oil injection, intravitreal 
injections, and autologous platelet injection. The number of operations prior to secondary MH formation and the 
number of subsequently required surgeries for MH closure were noted; MH was considered successfully closed 
when continuous inner retinal layers without intraretinal cysts were observed on OCT.
The best-corrected visual acuity (BCVA) was recorded by Snellen visual acuity and converted to logarithm 
of minimal angle of resolution (logMAR) scale for evaluation. We noted all available BCVA data at the following 
time intervals: prior to primary vitrectomy, onset of MH, and post-MH surgery at postoperative months 1, 3, 6, 
12, and 24, and finally, at the most recent follow-up visit.
Authors,
Journal (Year)
Secondary 
MH after 
PPV, Eyes 
(Incidence)
Mean Age, 
Years ± SD 
(Range)
Most Common 
Diagnosis, 
Eyes (%)
Mean Interval 
Between Primary 
PPV and MH 
Diagnosis, Month 
(Range)
ERM/CME 
Detected 
Prior to MH 
Diagnosis, 
Eyes (%)
High 
Myopia, 
Eyes (%)
MH Surgical 
Outcomes: 
Successful Closure 
Rate/Rate of 
Multiple Operations
Final Visual 
Outcome, 
Snellen’s VA 
(range):
Change in VA
Study Conclusions and 
Key Findings
Lee et al.2,
Retina (2010)
10 (0.2% 
over 5.3 
years)
56 ± 16
(27–78)
RD 5 (50%); 
VH due to 
PDR 4 (40%); 
Idio-pathic 
ERM 1 (10%)
26
(0.6–168)
ERM 4 (40%)/
CME 1 (10%) 3 (30%)
9 (90%) closed/0 
multiple ops
20/460 (20/21 
to counting 
fingers): 2-line 
decrease,
2 eyes (20%)
Relatively favourable 
outcomes, final VA 
dependent on underlying 
ocular pathology.
Garcia-Arumi 
et al.18, Retina 
(2011)
14 (0.6% 
after RD 
repair over 
13 years)
52
(29–70)
Macula-off RD 
14 (100%)
11
(0.8–78)
ERM 45% 
overall/CME 
no data
3 (21%) 14 (100%) closed/0 multiple ops
20/100 
(20/28–
20/400): 
14 (100%) 
improved 
compared to 
pre-op
Favourable MH closure 
rate, though limited 
functional VA outcome.
Schlenker 
et al.3, Can J 
Ophthalmol 
(2012)
9 (0.9% 
after RD 
repair over 
4.5 years)
49
(9–73)
RD 9 (100%): 
macula-off 
8 (89%), re-
current 5 (56%)
median 4
(0.07–22)
ERM 2 (22%)/
CME no data 1 (11%)
8 (89%) closed/2 
(22%) multiple ops
20/200 (20/50 
to counting 
fingers): 1-line 
increase,
5 eyes (56%)
CME may play a 
prominent role. 
Favourable MH closure 
rates, though visual 
prognosis remains 
guarded.
Fabian et al.8, 
Retina (2012)
7 (1.1% 
after RD 
repair over 
4.5 years)
60 ± 10
(50–79)
RD 7 (100%): 
macula-off 3 
(30%)
20
(1–48)
ERM 2 (29%)/
CME none (no data)
5 out of 7 (71%) 
closed/1 (14%) 
multiple ops
20/74 (20/25–
20/480): 
3 (43%) 
improved 
compared to 
pre-op
Suggests iatrogenic 
trauma during PPV, 
vitreoschisis, ILM 
traction may cause 
secondary MH.
Gao et 
al.10, Am J 
Ophthalmol 
(2013)
8 (19% after 
foveoschisis 
repair over 
10 years)
69 ± 13
(51–83)
Myopic 
foveoschisis 
(100%)
1.6
(1–3) (no data)
Myopia 
>6D or AXL 
>26.5 mm: 8 
(100%)
(no data) (no data)
Chorioretinal atrophy/
posterior staphyloma 
not significant. Loss of 
IS/OS line integrity risk 
factor for secondary MH 
development.
Medina et al.11,
Retina (2017)
15 (no 
data on 
incidence)
64
(50–86)
RD 15 (100%): 
macula-off 
9 (60%), re-
current 9 (60%)
4
(1–13)
ERM 11 
(73%)/CME 
none
Myopia 
>6D or AXL 
>26.5 mm: 
5 out of 9 
(56%)
11 (73%) closed/7 
(47%) multiple ops
20/267 (20/60 
to hand 
motions): 
2-line 
increase, 8 
eyes (53%)
Secondary MH may 
be associated with 
ERM, macula-off RD, 
recurrent RD, and high 
myopia. Limited visual 
improvement even after 
MH closure.
Khurana et 
al.14,
Retina (2017)
14 (no 
data on 
incidence)
61
(43–71)
RD 14 (100%): 
macula-off RD 
6 (43%)
median 15
(1–78)
ERM 14 
(100%)/CME 
none
(no data) 12 out of 12 (100%) closed/0 multiple ops
20/25 (20/20 
to counting 
fingers): 
13 (93%) 
improved 
compared to 
pre-op
ERM may play a role in 
the pathogenesis of MH.
Kang et al.,
Present Study
38 (0.6% 
over 10 
years)
57 ± 15
(18–77)
RD 9 (23.7%) 
with 5 macula-
off; secondary 
ERM 6 (15.8%)
median 2.3
(0.04–91)
ERM 19 
(50%)/CME 
none
AXL 
>28 mm: 6 
(15.8%)
34 out of 36 (94%)/10 
(28%) multiple ops
20/86 (20/25 
to counting 
fingers): 3-line 
increase, 18 
(47%)
Occurs most commonly 
after RD repair, 
associated with ERM. 
AXL ≥28 mm and poor 
BCVA at 3 months 
associated with limited 
outcome. History of 
macula-off RD risk factor 
for multiple surgeries for 
MH closure.
Table 5. Literature review — secondary macular hole formation after vitrectomy in different studies. 
AXL = axial length; BCVA = best-corrected visual acuity; CME = cystoid macular oedema; ERM = epiretinal 
membrane; ILM = internal limiting membrane; IS/OS = inner segment/outer segment; MH = macular 
hole; RD = retinal detachment; PDR = proliferative diabetic retinopathy; PPV = pars plana vitrectomy; 
SD = standard deviation; VA = visual acuity; VH = vitreous haemorrhage.
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Main outcome measures. The primary outcomes were the clinical characteristics associated with second-
ary MH, which included the indications for initial vitrectomy, features on optical coherence tomography, and 
adjuvant surgical techniques during the initial surgery. Patients were also grouped according to a 1-line or 3-lines 
visual gain and a 3-lines visual loss for comparison. Furthermore, in cases of eyes operated on for MH closure, 
we grouped the patients according to whether a single operation or multiple reoperations for MH closure were 
required. Thus, secondary outcomes included the change in BCVA at 24 months post-operation for MH closure, 
clinical factors associated with the need for multiple operations for MH closure and prognostic factors associated 
with the visual outcomes.
Statistical analysis. We performed statistical analyses using the IBM SPSS version 22.0 software (IBM 
Corp., Armonk, NY, USA). Kolmogorov-Smirnov tests were used to analyse the distribution of samples. The 
independent t and chi-square tests were used to compare the groups. Logistic regression analyses were per-
formed to assess the impacts of various patient and treatment factors on the outcomes. All data are presented as 
mean ± standard deviation. P values < 0.05 were considered statistically significant.
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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